Long-term monitoring of the ketogenic diet: Do's and Don'ts

Epilepsy Research

Volumn 100, Issue 3, 2012, Pages 261-266

  Bergqvist, A G Christina ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; Epilepsy; Ketogenic diet; Long term side effects

Indexed keywords

FATTY ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEGA 3 FATTY ACID; PROTON PUMP INHIBITOR;

ARTICLE; BONE DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; CONSTIPATION; DIET SUPPLEMENTATION; DIET THERAPY; EPILEPSY; FATTY ACID BLOOD LEVEL; FATTY LIVER; FECES IMPACTION; FLUID INTAKE; FOOD COMPOSITION; FRACTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GROWTH DISORDER; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; KETOGENIC DIET; LONG TERM CARE; METABOLISM; MINERAL DEFICIENCY; NEPHROLITHIASIS; OSTEOPENIA; OSTEOPOROSIS; PANCREATITIS; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; VITAMIN DEFICIENCY;

EPILEPSY; FOLLOW-UP STUDIES; HUMANS; KETOGENIC DIET; NERVOUS SYSTEM DISEASES; TREATMENT OUTCOME;

EID: 84864080468     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.05.020     Document Type: Article

References (46)

1. Bank I.M., Shemie S.D., Rosenblatt B., Bernard C., Mackie A.S. Sudden cardiac death in association with the ketogenic diet. Pediatr. Neurol. 2008, 39:429-431.
2. Bell K.L., Davies P.S. Prediction of height from knee height in children with cerebral palsy and non-disabled children. Ann. Hum. Biol. 2006, 33:493-499.
3. Bergqvist A.G., Chee C.M., Lutchka L., Rychik J., Stallings V.A. Selenium deficiency associated with cardiomyopathy: a complication of the ketogenic diet. Epilepsia 2003, 44:618-620.
4. Bergqvist A.G., Schall J.I., Stallings V.A. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia 2007, 48:66-71.
5. Bergqvist A.G., Schall J.I., Stallings V.A., Zemel B.S. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am. J. Clin. Nutr. 2008, 88:1678-1684.
6. Bertoli S., Cardinali S., Veggiotti P., Trentani C., Testolin G., Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutr. J. 2006, 5:14.
7. Best T.H., Franz D.N., Gilbert D.L., Nelson D.P., Epstein M.R. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000, 54:2328-2330.
8. Chesney D., Brouhard B.H., Wyllie E., Powaski K. Biochemical abnormalities of the ketogenic diet in children. Clin. Pediatr. 1999, 38:107-109.
9. Couch S.C., Schwarzman F., Carroll J., Koenigsberger D., Nordli D.R., Deckelbaum R.J., DeFelice A.R. Growth and nutritional outcomes of children treated with the ketogenic diet. J. Am. Diet. Assoc. 1999, 99:1573-1575.
10. Cunnane S.C. Metabolism of polyunsaturated fatty acids and ketogenesis: an emerging connection. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:237-241.
11. Dahlin M., Hjelte L., Nilsson S., Amark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res. 2007, 73:199-207.
12. Dekaban A.S. Plasma lipids in epileptic children treated with the high fat diet. Arch. Neurol. 1966, 15:177-184.
13. Fenton C., Chee C.M., Bergqvist A.G.C. Manipulation of types of fats and cholesterol intake can successfully improve the lipid profile while maintaining the efficacy of the ketogenic diet. Infant Child Adolesc. Nutr. 2009, 1:338-341.
14. Fitzpatrick L.A. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004, 5(Suppl. 2):S3-S15.
15. Fraser D.D., Whiting S., Andrew R.D., Macdonald E.A., Musa-Veloso K., Cunnane S.C. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 2003, 60:1026-1029.
16. Furth S.L., Casey J.C., Pyzik P.L., Neu A.M., Docimo S.G., Vining E.P., Freeman J.M., Fivush B.A. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr. Nephrol. 2000, 15:125-128.
17. Groesbeck D.K., Bluml R.M., Kossoff E.H. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child Neurol. 2006, 48:978-981.
18. Hahn T.J., Halstead L.R., DeVivo D.C. Disordered mineral metabolism produced by ketogenic diet therapy. Calcif. Tissue Int. 1979, 28:17-22.
19. Hassan A.M., Keene D.L., Whiting S.E., Jacob P.J., Champagne J.R., Humphreys P. Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr. Neurol. 1999, 21:548-552.
20. Hemingway C., Freeman J.M., Pillas D.J., Pyzik P.L. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001, 108:898-905.
21. Jung E., Chung J.Y., Kang H.C., Kim H.D. Improving tolerability of the ketogenic diet in patients with abnormal endoscopic findings. Brain Dev. 2008, 30:416-419.
22. Kang H.C., Chung D.E., Kim D.W., Kim H.D. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004, 45:1116-1123.
23. Kang H.C., Kim Y.J., Kim D.W., Kim H.D. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005, 46:272-279.
24. Kielb S., Koo H.P., Bloom D.A., Faerber G.J. Nephrolithiasis associated with the ketogenic diet. J. Urol. 2000, 164:464-466.
25. Kossoff E.H., Pyzik P.L., Furth S.L., Hladky H.D., Freeman J.M., Vining E.P. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002, 43:1168-1171.
26. Kossoff E.H., Zupec-Kania B.A., Amark P.E., Ballaban-Gil K.R., Christina Bergqvist A.G., Blackford R., Buchhalter J.R., Caraballo R.H., Helen Cross J., Dahlin M.G., Donner E.J., Klepper J., Jehle R.S., Kim H.D., Christiana Liu Y.M., Nation J., Nordli D.R., Pfeifer H.H., Rho J.M., Stafstrom C.E., Thiele E.A., Turner Z., Wirrell E.C., Wheless J.W., Veggiotti P., Vining E.P. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009, 50:304-317.
27. Kwiterovich P.O., Vining E.P., Pyzik P., Skolasky R., Freeman J.M. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003, 290:912-920.
28. Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol. Pathol. 2001, 54:311-316.
29. Liu Y.M., Williams S., Basualdo-Hammond C., Stephens D., Curtis R. A prospective study: growth and nutritional status of children treated with the ketogenic diet. J. Am. Diet. Assoc. 2003, 103:707-712.
30. Neal E.G., Chaffe H.M., Edwards N., Lawson M.S., Schwartz R.H., Cross J.H. Growth of children on classical and medium-chain triglyceride ketogenic diets. Pediatrics 2008, 122:e334-e340.
31. Nizamuddin J., Turner Z., Rubenstein J.E., Pyzik P.L., Kossoff E.H. Management and risk factors for dyslipidemia with the ketogenic diet. J. Child Neurol. 2008, 23:758-761.
32. Patel A., Pyzik P.L., Turner Z., Rubenstein J.E., Kossoff E.H. Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia 2010, 51:1277-1282.
33. Peterson S.J., Tangney C.C., Pimentel-Zablah E.M., Hjelmgren B., Booth G., Berry-Kravis E. Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy. J. Am. Diet. Assoc. 2005, 105:718-725.
34. Porta N., Vallee L., Boutry E., Fontaine M., Dessein A.F., Joriot S., Cuisset J.M., Cuvellier J.C., Auvin S. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure 2009, 18:359-364.
35. Sampath A., Kossoff E.H., Furth S.L., Pyzik P.L., Vining E.P. Kidney stones and the ketogenic diet: risk factors and prevention. J. Child Neurol. 2007, 22:375-378.
36. Schwartzkroin P.A. Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res. 1999, 37:171-180.
37. Sharman M.J., Kraemer W.J., Love D.M., Avery N.G., Gomez A.L., Scheett T.P., Volek J.S. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J. Nutr. 2002, 132.
38. Shellhaas R.A., Barks A.K., Joshi S.M. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy. Pediatr. Neurol. 2010, 42:422-426.
39. Sheth R.D., Binkley N., Hermann B.P. Progressive bone deficit in epilepsy. Neurology 2008, 70:170-176.
40. Spulber G., Spulber S., Hagenas L., Amark P., Dahlin M. Growth dependence on insulin-like growth factor-1 during the ketogenic diet. Epilepsia 2009, 50:297-303.
41. Stewart W.A., Gordon K., Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J. Child Neurol. 2001, 16:682.
42. Vestergaard P. Epilepsy, osteoporosis and fracture risk-a meta-analysis. Acta Neurol. Scand. 2005, 112:277-286.
43. Vining E.P., Pyzik P., McGrogan J., Hladky H., Anand A., Kriegler S., Freeman J.M. Growth of children on the ketogenic diet. Dev. Med. Child Neurol. 2002, 44:796-802.
44. Williams S., Basualdo-Hammond C., Curtis R., Schuller R. Growth retardation in children with epilepsy on the ketogenic diet: a retrospective chart review. J. Am. Diet. Assoc. 2002, 102:405-407.
45. Yudkoff M., Daikhin Y., Horyn O., Nissim I., Nissim I. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia 2008, 49(Suppl. 8):73-75.
46. Zupec-Kania B., Zupanc M.L. Long-term management of the ketogenic diet: seizure monitoring, nutrition, and supplementation. Epilepsia 2008, 49(Suppl. 8):23-26.